| 2022 | Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | BNT162b2 접종과 면역관문억제제 치료 이후 발생한 이상 반응 1예
| Korean Journal of Medicine |
| 2017 | BRCA1 and BRCA2 mutation predictions using the BRCAPRO and Myriad models in Korean ovarian cancer patients | GYNECOLOGIC ONCOLOGY |
| 2018 | Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation
| PLOS ONE |
| 2021 | Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor
| ADVANCED SCIENCE |
| 2023 | CEACAM1 Marks Highly Suppressive Intratumoral Regulatory T Cells for Targeted Depletion Therapy | CLINICAL CANCER RESEARCH |
| 2018 | Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
| BMC CANCER |
| 2019 | Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
| CANCER RESEARCH AND TREATMENT |
| 2023 | Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
| SCIENTIFIC REPORTS |
| 2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2018 | Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models
| CANCER RESEARCH AND TREATMENT |
| 2017 | Comparison of Clinical Outcomes of BRCA1/2 Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
| CANCER RESEARCH AND TREATMENT |
| 2023 | Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2020 | Comparison of outcomes between the one-step and two-step sentinel lymph node mapping techniques in endometrial cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2021 | Comparison of Serum Anti-Mullerian Hormone-Level Changes in Single-Port Laparoscopic Endometriotic and Non-Endometriotic Ovarian Cyst Enucleations
| Journal of Menopausal Medicine |
| 2021 | Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging
| Obstetrics & Gynecology Science |
| 2023 | Comparison of Single-Port Laparoscopy with Other Surgical Approaches in Endometrial Cancer Surgical Staging: Propensity-Score-Matched Analysis
| CANCERS |
| 2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2020 | Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy | EUROPEAN JOURNAL OF CANCER |
| 2015 | Controversies in the management of endometrial cancer: a survey of the Korean Gynecologic Oncology Group
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2015 | Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2021 | CT-Based Fagotti Scoring System for Non-Invasive Prediction of Cytoreduction Surgery Outcome in Patients with Advanced Ovarian Cancer
| KOREAN JOURNAL OF RADIOLOGY |
| 2017 | Delayed hemorrhage effect of local anesthesia with epinephrine in the loop electrosurgical excisional procedure
| Obstetrics & Gynecology Science |
| 2016 | Detecting Asymptomatic Recurrence in Early-Stage Endometrial Cancer: The Value of Vaginal Cytology, Imaging Studies, and CA-125 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2018 | Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-Gene Panels: Beyond BRCA1/2
| CANCER RESEARCH AND TREATMENT |
| 2018 | Diagnostic Value of 18F-FDG PET/CT and MRI in the Preoperative Evaluation of Uterine Carcinosarcoma | NUCLEAR MEDICINE AND MOLECULAR IMAGING |
| 2017 | Difference in Practice Patterns in the Management of Endometrial Cancer: A Survey of the Members of 4 East Asian Gynecologic Oncology Groups | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2018 | Distinct Clinical Courses of Epithelial Ovarian Cancer with Mutations in BRCA1 5' and 3' Exons | Anticancer Research |
| 2023 | Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial | LANCET ONCOLOGY |
| 2022 | Durvalumab, in combination with and following chemoradiotherapy, in locally advanced cervical cancer: results from the phase 3 international, randomized, double-blind, placebo-controlled calla trial | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2017 | Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas
| ONCOTARGET |
| 2020 | Early Assessment of Response to Neoadjuvant Chemotherapy with 18F-FDG-PET/CT in Patients with Advanced-Stage Ovarian Cancer
| CANCER RESEARCH AND TREATMENT |
| 2020 | Effect of bupivacaine versus lidocaine local anesthesia on postoperative pain reduction in single-port access laparoscopic adnexal surgery using propensity score matching
| Obstetrics & Gynecology Science |
| 2020 | Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2021 | Effects of Korean Red Ginseng ( Panax ginseng C.A. Meyer) on Menopausal Symptoms in Premenopausal Women After Gynecologic Cancer Surgery: A Double-Blind, Randomized Controlled Trial | JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE |
| 2023 | Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results. | JOURNAL OF CLINICAL ONCOLOGY |
| 2018 | Evaluation of various kinetic parameters of CA-125 in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy.
| PLOS ONE |
| 2018 | Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer | GYNECOLOGIC ONCOLOGY |
| 2017 | External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
| 2016 | Genetic analysis of ovarian microcystic stromal tumor
| Obstetrics & Gynecology Science |
| 2021 | Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix | MODERN PATHOLOGY |
| 2019 | Genetic Profiles Associated with Chemoresistance in Patient-Derived Xenograft Models of Ovarian Cancer
| Cancer Research and Treatment |
| 2023 | Genomic hypomethylation in cell-free DNA predicts responses to checkpoint blockade in lung and breast cancer
| SCIENTIFIC REPORTS |
| 2020 | Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy | INTERNATIONAL JOURNAL OF CANCER |
| 2020 | Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
| BMC CANCER |
| 2023 | Globally shared TCR repertoires within the tumor-infiltrating lymphocytes of patients with metastatic gynecologic cancer
| SCIENTIFIC REPORTS |
| 2019 | How to use immune checkpoint inhibitor in ovarian cancer?
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2023 | Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy | JAMA SURGERY |
| 2017 | Identification of a Novel BRCA1 Pathogenic Mutation in Korean Patients Following Reclassification of BRCA1 and BRCA2 Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
| CANCER RESEARCH AND TREATMENT |
| 2022 | Identification of Lynch Syndrome in Patients with Endometrial Cancer Based on a Germline Next Generation Sequencing Multigene Panel Test
| CANCERS |
| 2015 | Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion
| BMC CANCER |
| 2022 | IMMUNE PROPERTIES OF TUMOR-INFILTRATING LYMPHOCYTES IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2015 | Impact of guideline adherence on patient outcomes in early-stage epithelial ovarian cancer | EJSO |
| 2018 | Impact of increased utilization of neoadjuvant chemotherapy on survival in patients with advanced ovarian cancer: experience from a comprehensive cancer center.
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
